travellers 译为旅行者。因此，译文为：旅行者用伤寒结合疫苗预防伤寒。
Prevention of enteric fever in travellers with typhoid conjugate vaccines.
机构信息
Oxford Vaccine Group, Department of Paediatrics, University of Oxford.
出版信息
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay120.
Abstract
The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a vaccines
摘要
2018 年世卫组织关于伤寒疫苗的立场文件表明，优先使用新一代伤寒结合疫苗，而非现有的注射用 Vi 多糖（Vi-PS）疫苗和口服减毒 Ty21a 疫苗。
相似文献
1
Prevention of enteric fever in travellers with typhoid conjugate vaccines. travellers 译为旅行者。因此，译文为：旅行者用伤寒结合疫苗预防伤寒。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay120.
2
Madagascar should introduce typhoid conjugate vaccines now.马达加斯加现在应该引入伤寒结合疫苗。
Lancet. 2018 Oct 13;392(10155):1309-1310. doi: 10.1016/S0140-6736(18)31882-8.
3
Progress in the overall understanding of typhoid fever: implications for vaccine development.伤寒研究进展：对疫苗研发的启示。
Expert Rev Vaccines. 2020 Apr;19(4):367-382. doi: 10.1080/14760584.2020.1750375. Epub 2020 Apr 17.
4
Typhoid vaccination: the Asian experience.伤寒疫苗接种：亚洲的经验。
Expert Rev Vaccines. 2008 Jul;7(5):547-60. doi: 10.1586/14760584.7.5.547.
5
Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009.用于伤寒的结合疫苗：2009年在印度新德里组织召开的一次会议的会议记录
J Infect Dev Ctries. 2010 Jun 30;4(6):404-11.
6
Vaccination against typhoid fever in travellers: a cost-effectiveness approach.旅行者伤寒疫苗接种：一种成本效益方法。
Clin Microbiol Infect. 2004 Aug;10(8):681-3. doi: 10.1111/j.1469-0691.2004.00901.x.
7
Mass vaccination to control epidemic and endemic typhoid fever.大规模接种疫苗以控制流行性和地方性伤寒热。
Curr Top Microbiol Immunol. 2006;304:231-46. doi: 10.1007/3-540-36583-4_13.
8
The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines.非洲严重伤寒项目强调需要广泛部署伤寒结合疫苗。
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S413-S416. doi: 10.1093/cid/ciz637.
9
On the Ground in Malawi-First Typhoid Conjugate Vaccine Study in Africa.在马拉维实地开展——非洲首个伤寒结合疫苗研究
Am J Trop Med Hyg. 2019 Jun;100(6):1299-1300. doi: 10.4269/ajtmh.19-0014.
10
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?用于预防儿童伤寒热的Vi多糖-蛋白质结合疫苗：希望还是炒作？
Expert Rev Vaccines. 2007 Jun;6(3):293-5. doi: 10.1586/14760584.6.3.293.
引用本文的文献
1
Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever.评估伤寒沙门氏菌的致病性与预防措施：疫苗接种在抗击伤寒热中的关键作用。
Int J Mol Sci. 2025 Apr 23;26(9):3981. doi: 10.3390/ijms26093981.
2
Burden of Culture Confirmed Enteric Fever Cases in Karachi, Pakistan: Surveillance For Enteric Fever in Asia Project (SEAP), 2016-2019.巴基斯坦卡拉奇确认文化负担肠热病病例：亚洲肠热病监测项目（SEAP），2016-2019 年。
Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S214-S221. doi: 10.1093/cid/ciaa1308.
3
Dengue vaccine development by the year 2020: challenges and prospects.2020 年登革热疫苗的开发：挑战与展望。
Curr Opin Virol. 2020 Aug;43:71-78. doi: 10.1016/j.coviro.2020.09.004. Epub 2020 Oct 18.
4
Epidemiological and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of Their Isolates: a GeoSentinel Analysis.伤寒国际旅行者的流行病学和临床特征及其分离株的抗生素耐药谱：一项全球哨点分析。
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01084-20.
5
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature.旅行相关伤寒：科学文献综述。
Int J Environ Res Public Health. 2020 Jan 18;17(2):615. doi: 10.3390/ijerph17020615.
本文引用的文献
1
Enteric fever among children: 50 cases in a French tertiary care centre.儿童肠热病：法国一家三级保健中心的 50 例病例。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay059.
2
Vaccines for preventing typhoid fever.预防伤寒热的疫苗。
Cochrane Database Syst Rev. 2018 May 31;5(5):CD001261. doi: 10.1002/14651858.CD001261.pub4.
3
Typhoid vaccines: WHO position paper, March 2018 - Recommendations.伤寒疫苗：世卫组织立场文件，2018 年 3 月-建议。
Vaccine. 2019 Jan 7;37(2):214-216. doi: 10.1016/j.vaccine.2018.04.022. Epub 2018 Apr 13.
4
Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV).Vi 多糖-破伤风类毒素伤寒结合疫苗（Typbar TCV）的血清效力。
Clin Infect Dis. 2018 Jun 18;67(1):18-24. doi: 10.1093/cid/cix1145.
5
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.采用伤寒沙门氏菌人体感染模型评估 Vi 结合破伤风类毒素疫苗在预防伤寒中的效果和免疫原性：一项随机对照、2b 期临床试验。
Lancet. 2017 Dec 2;390(10111):2472-2480. doi: 10.1016/S0140-6736(17)32149-9. Epub 2017 Sep 28.
6
Global travel patterns: an overview.全球旅行模式：概述
J Travel Med. 2017 Jul 1;24(4). doi: 10.1093/jtm/tax007.
7
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.在伤寒流行地区，健康婴儿、儿童和成人中 Vi 多糖-破伤风类毒素结合疫苗（Typbar-TCV）的安全性和免疫原性：一项多中心、2 队列、开放性、双盲、随机对照 3 期研究。
Clin Infect Dis. 2015 Aug 1;61(3):393-402. doi: 10.1093/cid/civ295. Epub 2015 Apr 13.
8
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.中低收入国家伤寒负担：基于系统文献的更新，包括风险因素调整。
Lancet Glob Health. 2014 Oct;2(10):e570-80. doi: 10.1016/S2214-109X(14)70301-8.
9
Cases of malaria, hepatitis A, and typhoid fever among VFRs, Quebec (Canada).旅行者中疟疾、甲型肝炎和伤寒的病例，魁北克（加拿大）。
J Travel Med. 2011 Nov-Dec;18(6):373-8. doi: 10.1111/j.1708-8305.2011.00556.x. Epub 2011 Oct 12.
10
Typhoid fever in travelers: who should be targeted for prevention?旅行者中的伤寒热：预防应针对哪些人群？
Clin Infect Dis. 2004 Jul 15;39(2):186-91. doi: 10.1086/421945. Epub 2004 Jul 1.
Zotero 插件